MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 31.08.2022
Land |
 Australien |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
2.41 B |
Marktkapitalisierung |
$ 8.71 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market |  USA |
 |
Adagene
ADAG
|
$ 2.4 | -3.61 % | $ 135 M | Nasdaq Global Market |  China |
 |
Aptorum Group Limited
APM
|
$ 0.97 | 0.81 % | $ 5.29 M | Nasdaq Global Select Market | China |
 |
Biogen
BIIB
|
$ 172.5 | 0.53 % | $ 25.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
BioNTech SE
BNTX
|
$ 117.41 | 1.23 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Catalyst Biosciences
CBIO
|
$ 12.1 | -5.47 % | $ 797 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Cellectis S.A.
CLLS
|
$ 4.16 | -5.88 % | $ 116 M | Nasdaq Global Market | France |
 |
BioXcel Therapeutics
BTAI
|
$ 1.79 | -1.92 % | $ 4.54 M | Nasdaq Global Select Market,SPB | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.98 | -3.75 % | $ 908 M | Nasdaq Capital Market |  Israel |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Ascendis Pharma A/S
ASND
|
$ 231.73 | -1.55 % | $ 5 B | Nasdaq Global Select Market |  Danmark |
 |
Burford Capital Limited
BUR
|
$ 9.72 | -0.31 % | $ 1.57 B | NYSE | Britain |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Cytokinetics, Incorporated
CYTK
|
$ 63.82 | 0.65 % | $ 7.15 M | Nasdaq Global Select Market,SPB | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market |  Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 67.09 | 0.06 % | $ 8.97 B | Nasdaq Global Select Market,SPB | USA |
 |
Compugen Ltd.
CGEN
|
$ 2.05 | -2.15 % | $ 184 M | Nasdaq Global Market,SPB | Israel |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 4.41 | -1.34 % | $ 9.6 B | NYSE American | Israel |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 26.4 | 1.85 % | $ 1.28 B | Nasdaq Global Select Market | USA |
 |
Coherus BioSciences
CHRS
|
$ 2.27 | 10.19 % | $ 214 M | Nasdaq Global Market | USA |
 |
Amneal Pharmaceuticals
AMRX
|
$ 13.54 | 1.12 % | $ 4.18 B | NYSE | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 26.48 | 2.16 % | $ 1.71 M | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Aytu BioScience
AYTU
|
$ 2.73 | 1.11 % | $ 17.1 M | Nasdaq Capital Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |
 |
AstraZeneca PLC
AZN
|
$ 94.12 | 1.25 % | $ 96.9 B | Nasdaq Global Select Market | Britain |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |